NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater...
Q2 2026
Jul 23, 2026
Q1 2026
Apr 30, 2026
FY 2025
Feb 26, 2026
Q4 2025
Q3 2025
Oct 30, 2025